HOME
LOGIN/REGISTER
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Most Read Articles
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1509
Therapeutics (AZCERT) has recently added the proton pump inhibitors (PPIs) omeprazole (Prilosec, and others), esomeprazole (Nexium, and others), lansoprazole (Prevacid, and others), and pantoprazole (Protonix, and generics) to its lists of Drugs with Conditional Risk of Torsades de Pointes (TdP) and Drugs to Avoid in Patients with Congenital Long QT Syndrome.1

PPIs do not directly cause prolongation of the QT interval, but they can cause hypomagnesemia, which is often accompanied by...  read more...
More from issue 1509
Coming Soon
Drugs for Psychotic Disorders
Safety of Celecoxib (Celebrex) Revisited
Ustekinumab (Stelara) for Crohn’s Disease
Previous Issues
© 2016 The Medical Letter, Inc.